組換えDNA技術の世界市場レポート 2025年

組換えDNA技術の市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）9.4％で1兆3,187億2,000万米ドルに成長します。予測期間の成長は、慢性疾患の増加、新興バイオテクノロジー企業、バイオテクノロジーへの資金提供の増加、バイオテクノロジー市場のグローバル化、消費者の受容と教育に起因しています。予測期間の主な動向には、科学の進歩、遺伝子編集の進歩、細胞・遺伝子治療、RNA治療薬の開発、希少疾患の治療応用、AI、データ統合などがあります。

慢性疾患の有病率の上昇が組換えDNA技術市場の成長を牽引すると予測されます。慢性疾患は、継続的な治療を必要としたり、日常生活を制限したりする1年以上続く疾患と定義され、ヘルスケアのニーズに大きな影響を与えます。組換えDNA技術は、医薬品に使用されるバイオ医薬品タンパク質の開発を可能にし、病気の治癒を目指し、欠陥のある遺伝子を健康な遺伝子に置き換える遺伝子治療を容易にすることで、ヘルスケアを一変させました。例えば、2024年2月、スイスに本部を置く政府間機関である世界保健機関（WHO）は、2050年までに新たながん患者が3,500万人を超え、2022年の推定2,000万人から77％増加すると予測しました。このように、慢性疾患の増加が組換えDNA技術市場の成長を促進しています。

遺伝子組換え作物の進歩の高まりが、今後の組換えDNA技術市場の拡大を促進すると予測されています。遺伝子組換え作物とは、バイオテクノロジーを駆使して遺伝子レベルで意図的に改変された植物のことです。組換えDNA（rDNA）技術は、遺伝子組換え（GM）作物の開発において、望ましい特性を持つ遺伝子の単離、組換えDNAの作成、宿主作物細胞への挿入、成功した組込みの選択とスクリーニング、遺伝子組換え植物の再生、形質発現の検証、野外試験の実施、規制当局の承認の確保、そして最終的に特性が強化された作物の商品化によって利用されます。例えば、2023年12月、米国の政府機関である米国農務省は、カナダが主にキャノーラ、大豆、トウモロコシを含む遺伝子組換え（GE）作物を1,170万ヘクタール作付けしたと報告しました。これは前年から4％増加したことになりますが、これは主にキャノーラの作付面積が拡大したためです。このように、遺伝子組換え作物の開発が進み、組換えDNA技術市場の成長を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の組換えDNA技術市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の組換えDNA技術市場：成長率分析
• 世界の組換えDNA技術市場の実績：規模と成長、2019～2024年
• 世界の組換えDNA技術市場の予測：規模と成長、2024～2029年、2034年
• 世界の組換えDNA技術総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の組換えDNA技術市場：製品タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 組換えタンパク質医薬品
• ワクチン
• 遺伝子組換え作物
• 発現システム
• 細胞および遺伝子治療
• 遺伝子編集
• 世界の組換えDNA技術市場：コンポーネントタイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 発現システム
• クローニングベクター
• 世界の組換えDNA技術市場：用途タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 食品と農業
• 健康と疾病
• 環境
• その他
• 世界の組換えDNA技術市場：最終用途別、実績と予測、2019～2024年、2024～2029年、2034年
• バイオテクノロジーおよび製薬会社
• 学術機関および政府研究機関
• その他
• 世界の組換えDNA技術市場：組換えタンパク質医薬品のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ホルモン
• 成長因子
• 世界の組換えDNA技術市場：ワクチンのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 組換えウイルスワクチン
• 組換え細菌ワクチン
• サブユニットワクチン
• 世界の組換えDNA技術市場：遺伝子組換え作物のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 除草剤耐性作物
• 昆虫抵抗性作物
• 栄養強化作物
• 世界の組換えDNA技術市場：発現システムのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 細菌発現システム
• 酵母発現システム
• 哺乳類発現システム
• 世界の組換えDNA技術市場：細胞および遺伝子治療のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 細胞ベースの治療法
• 遺伝子置換療法
• CAR T細胞療法
• 世界の組換えDNA技術市場：遺伝子編集のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• CRISPRまたはCas9テクノロジー
• TALEN（転写活性化因子様エフェクターヌクレアーゼ）
• ZFN（ジンクフィンガーヌクレアーゼ）

第7章 地域別・国別分析

• 世界の組換えDNA技術市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の組換えDNA技術市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 組換えDNA技術市場：競合情勢
• 組換えDNA技術市場：企業プロファイル
  • Profacgen BioTech Corp. Overview, Products and Services, Strategy and Financial Analysis
  • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • GenScript Biotech Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novo Nordisk A/S
• Eli Lilly and Company
• Sanofi S.A.
• Merck & Co. Inc.
• Biogen Inc.
• GlaxoSmithKline PLC
• New England Biolabs Inc.
• Bayer CropScience
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd
• Regeneron Pharmaceuticals Inc.
• Gilead Sciences Inc.
• Moderna Inc.
• Vertex Pharmaceuticals Incorporated
• CRISPR Therapeutics AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 組換えDNA技術市場2029年：新たな機会を提供する国
• 組換えDNA技術市場2029年：新たな機会を提供するセグメント
• 組換えDNA技術市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Recombinant DNA technology denotes the fusion of DNA molecules from diverse organisms, integrating them into a host organism to create new genetic combinations beneficial across scientific, medical, agricultural, and industrial domains. This technology plays a pivotal role in addressing health concerns by facilitating the development of novel medications and vaccines.

Within the realm of recombinant DNA technology, key product categories encompass recombinant protein drugs, vaccines, genetically modified crops, expression systems, cell and gene therapy, and gene editing. Notably, recombinant protein drugs serve crucial roles in biochemical analysis and medical diagnostics within human healthcare, including the production of antibodies, medicines, and vaccines. Renowned for their potency and rapid development compared to small molecules, these drugs are considered safer due to their reduced off-target adverse effects. This category comprises components like expression systems and cloning vectors. The extensive applications of recombinant DNA technology span various sectors such as food and agriculture, health and disease management, environmental interventions, and other diverse areas. This technology finds practical usage in biotechnology and pharmaceutical companies, academic and government research institutions, and various other end-use industries. Its impact is notably significant across a wide spectrum of fields and industries.

The recombinant DNA technology market research report is one of a series of new reports from The Business Research Company that provides recombinant DNA technology market statistics, including recombinant DNA technology industry global market size, regional shares, competitors with an recombinant DNA technology market share, detailed recombinant DNA technology market segments, market trends and opportunities, and any further data you may need to thrive in the recombinant DNA technology industry. This recombinant DNA technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The recombinant DNA technology market size has grown strongly in recent years. It will grow from $858.94 billion in 2024 to $920.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to healthcare demands, biopharmaceutical industry growth, rising investments in R&D, emergence of personalized medicine.

The recombinant DNA technology market size is expected to see strong growth in the next few years. It will grow to $1318.72 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to rising chronic diseases, emerging biotech startups, increasing funding in biotech, globalization of biotech markets, consumer acceptance and education. Major trends in the forecast period include scientific advancements, gene editing advancements, cell and gene therapies, development of RNA therapeutics, therapeutic applications in rare diseases, AI and data integration.

The rising prevalence of chronic diseases is anticipated to drive the growth of the recombinant DNA technology market. Chronic diseases, defined as conditions lasting a year or more that require ongoing medical attention or limit daily activities, significantly impact healthcare needs. Recombinant DNA technology has transformed healthcare by enabling the development of biopharmaceutical proteins used in medications and facilitating gene therapy to replace defective genes with healthy ones, aiming for disease cures. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that by 2050, there would be over 35 million new cancer cases, reflecting a 77% increase from the estimated 20 million cases in 2022. Thus, the rise in chronic diseases is propelling the growth of the recombinant DNA technology market.

The growing advancement of genetically modified crops is projected to drive the expansion of the recombinant DNA technology market in the future. Genetically modified crops are plants that have been intentionally altered at the genetic level using biotechnological methods. Recombinant DNA (rDNA) technology is utilized in the development of genetically modified (GM) crops by isolating genes that provide desired traits, creating recombinant DNA, inserting it into host crop cells, selecting and screening for successful integrations, regenerating transgenic plants, verifying trait expression, conducting field trials, securing regulatory approvals, and ultimately commercializing crops with enhanced characteristics. For example, in December 2023, the United States Department of Agriculture, a US-based government agency, reported that Canada planted 11.7 million hectares of genetically engineered (GE) crops, mainly including canola, soybeans, and corn. This marks a four percent increase from the previous year, largely due to the expansion of canola planting areas. Consequently, the growing development of genetically modified crops is fueling the growth of the recombinant DNA technology market.

Technological advancement is a significant trend within the recombinant DNA technology market. Leading companies in this sector are concentrating on innovative technologies to maintain their competitive edge. For example, in August 2022, Bluebird Bio, Inc., a US-based biotechnology firm, introduced ZYNTEGLO, which received approval from the U.S. Food and Drug Administration (FDA). This one-time gene therapy addresses beta-thalassemia by targeting its genetic cause, providing patients with the opportunity to achieve independence from regular red blood cell transfusions. ZYNTEGLO utilizes an ex-vivo lentiviral vector to modify patient cells and is the first FDA-approved gene therapy for this condition in the United States. This groundbreaking therapy significantly alleviates the lifelong burden associated with managing beta-thalassemia.

Moreover, major players within the recombinant DNA technology sector are actively engaged in developing new vaccines to sustain their market presence. For instance, Variation Biotechnologies Inc. launched PreHevbrio(TM) [Hepatitis B Vaccine (Recombinant)] in March 2022 in the United States. This vaccine, approved by the FDA in November 2021, incorporates essential hepatitis B surface antigens, ensuring a robust immune response when administered in a 3-dose series. The development and launch of such vaccines represent a significant stride within the recombinant DNA technology market.

In January 2022, Thermo Fisher Scientific, a prominent supplier based in the US specializing in scientific instrumentation, reagents, consumables, and software services, finalized the acquisition of PeproTech for a sum of $1.85 billion. This strategic acquisition aimed to complement Thermo Fisher's existing line of cell culture media products by integrating PeproTech's extensive portfolio of recombinant proteins. By combining these offerings, Thermo Fisher sought to deliver enhanced advantages to its customers through an integrated solution. PeproTech, Inc., the acquired company, is recognized for its expertise as a US-based developer and manufacturer of bioscience reagents, particularly renowned for its recombinant proteins.

Major companies operating in the recombinant DNA technology market are Profacgen BioTech Corp., Amgen Inc., Novartis International AG, GenScript Biotech Corporation, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Co. Inc., Biogen Inc., GlaxoSmithKline PLC, New England Biolabs Inc., Bayer CropScience, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc., Gilead Sciences Inc., Moderna Inc., Vertex Pharmaceuticals Incorporated, CRISPR Therapeutics AG, Editas Medicine Inc., bluebird bio Inc., Illumina Inc., Qiagen N.V., Lonza Group AG, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Becton Dickinson and Company, Sartorius AG, Abcam PLC, Horizon Discovery Group PLC, Integrated DNA Technologies Inc., Twist Bioscience Corporation, Synthego Corporation, Codex DNA Inc., InvivoGen, Eurofins Scientific SE, Sarepta Therapeutics Inc., Sangamo Therapeutics Inc.

North America was the largest region in the recombinant DNA technology market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recombinant dna technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the recombinant dna technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The recombinant DNA technology market includes revenues earned by entities by expression systems including mammalian, bacteria, yeast, and baculovirus / insect. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Recombinant DNA Technology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on recombinant dna technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for recombinant dna technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The recombinant dna technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Recombinant Protein Drugs; Vaccines; Genetically Modified Crops; Expression Systems; Cell And Gene Therapy; Gene Editing
• 2) By Component Type: Expression System; Cloning Vector
• 3) By Application Type: Food And Agriculture; Health And Disease; Environment; Other Application Types
• 4) By End-Use Type: Biotechnology And Pharmaceutical Companies; Academic And Government Research Institutes; Other End-Use Types
• Subsegments:
• 1) By Recombinant Protein Drugs: Hormones; Growth Factors
• 2) By Vaccines: Recombinant Viral Vaccines; Recombinant Bacterial Vaccines; Subunit Vaccines
• 3) By Genetically Modified Crops: Herbicide-Tolerant Crops; Insect-Resistant Crops; Nutritionally Enhanced Crop
• 4) By Expression Systems: Bacterial Expression Systems; Yeast Expression Systems; Mammalian Expression Systems
• 5) By Cell And Gene Therapy: Cell-Based Therapies; Gene Replacement Therapies; CAR T-Cell Therapies
• 6) By Gene Editing: CRISPR Or Cas9 Technologies; TALENs (Transcription Activator-Like Effector Nucleases); ZFNs (Zinc Finger Nucleases)
• Companies Mentioned: Profacgen BioTech Corp.; Amgen Inc.; Novartis International AG; GenScript Biotech Corporation; Pfizer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Recombinant DNA Technology Market Characteristics

3. Recombinant DNA Technology Market Trends And Strategies

4. Recombinant DNA Technology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Recombinant DNA Technology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Recombinant DNA Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Recombinant DNA Technology Market Growth Rate Analysis
• 5.4. Global Recombinant DNA Technology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Recombinant DNA Technology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Recombinant DNA Technology Total Addressable Market (TAM)

6. Recombinant DNA Technology Market Segmentation

• 6.1. Global Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Protein Drugs
• Vaccines
• Genetically Modified Crops
• Expression Systems
• Cell and Gene Therapy
• Gene Editing
• 6.2. Global Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Expression System
• Cloning Vector
• 6.3. Global Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Food And Agriculture
• Health And Disease
• Environment
• Other Application Types
• 6.4. Global Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biotechnology And Pharmaceutical Companies
• Academic And Government Research Institutes
• Other End-Use Types
• 6.5. Global Recombinant DNA Technology Market, Sub-Segmentation Of Recombinant Protein Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormones
• Growth Factors
• 6.6. Global Recombinant DNA Technology Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Viral Vaccines
• Recombinant Bacterial Vaccines
• Subunit Vaccines
• 6.7. Global Recombinant DNA Technology Market, Sub-Segmentation Of Genetically Modified Crops, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Herbicide-Tolerant Crops
• Insect-Resistant Crops
• Nutritionally Enhanced Crop
• 6.8. Global Recombinant DNA Technology Market, Sub-Segmentation Of Expression Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacterial Expression Systems
• Yeast Expression Systems
• Mammalian Expression Systems
• 6.9. Global Recombinant DNA Technology Market, Sub-Segmentation Of Cell And Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell-Based Therapies
• Gene Replacement Therapies
• CAR T-Cell Therapies
• 6.10. Global Recombinant DNA Technology Market, Sub-Segmentation Of Gene Editing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR or Cas9 Technologies
• TALENs (Transcription Activator-Like Effector Nucleases)
• ZFNs (Zinc Finger Nucleases)

7. Recombinant DNA Technology Market Regional And Country Analysis

• 7.1. Global Recombinant DNA Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Recombinant DNA Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Recombinant DNA Technology Market

• 8.1. Asia-Pacific Recombinant DNA Technology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Recombinant DNA Technology Market

• 9.1. China Recombinant DNA Technology Market Overview
• 9.2. China Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Recombinant DNA Technology Market

• 10.1. India Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Recombinant DNA Technology Market

• 11.1. Japan Recombinant DNA Technology Market Overview
• 11.2. Japan Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Recombinant DNA Technology Market

• 12.1. Australia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Recombinant DNA Technology Market

• 13.1. Indonesia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Recombinant DNA Technology Market

• 14.1. South Korea Recombinant DNA Technology Market Overview
• 14.2. South Korea Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Recombinant DNA Technology Market

• 15.1. Western Europe Recombinant DNA Technology Market Overview
• 15.2. Western Europe Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Recombinant DNA Technology Market

• 16.1. UK Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Recombinant DNA Technology Market

• 17.1. Germany Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Recombinant DNA Technology Market

• 18.1. France Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Recombinant DNA Technology Market

• 19.1. Italy Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Recombinant DNA Technology Market

• 20.1. Spain Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Recombinant DNA Technology Market

• 21.1. Eastern Europe Recombinant DNA Technology Market Overview
• 21.2. Eastern Europe Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Recombinant DNA Technology Market

• 22.1. Russia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Recombinant DNA Technology Market

• 23.1. North America Recombinant DNA Technology Market Overview
• 23.2. North America Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Recombinant DNA Technology Market

• 24.1. USA Recombinant DNA Technology Market Overview
• 24.2. USA Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Recombinant DNA Technology Market

• 25.1. Canada Recombinant DNA Technology Market Overview
• 25.2. Canada Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Recombinant DNA Technology Market

• 26.1. South America Recombinant DNA Technology Market Overview
• 26.2. South America Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Recombinant DNA Technology Market

• 27.1. Brazil Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Recombinant DNA Technology Market

• 28.1. Middle East Recombinant DNA Technology Market Overview
• 28.2. Middle East Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Recombinant DNA Technology Market

• 29.1. Africa Recombinant DNA Technology Market Overview
• 29.2. Africa Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Recombinant DNA Technology Market Competitive Landscape And Company Profiles

• 30.1. Recombinant DNA Technology Market Competitive Landscape
• 30.2. Recombinant DNA Technology Market Company Profiles
  • 30.2.1. Profacgen BioTech Corp. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GenScript Biotech Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Recombinant DNA Technology Market Other Major And Innovative Companies

• 31.1. Novo Nordisk A/S
• 31.2. Eli Lilly and Company
• 31.3. Sanofi S.A.
• 31.4. Merck & Co. Inc.
• 31.5. Biogen Inc.
• 31.6. GlaxoSmithKline PLC
• 31.7. New England Biolabs Inc.
• 31.8. Bayer CropScience
• 31.9. Thermo Fisher Scientific Inc.
• 31.10. F. Hoffmann-La Roche Ltd
• 31.11. Regeneron Pharmaceuticals Inc.
• 31.12. Gilead Sciences Inc.
• 31.13. Moderna Inc.
• 31.14. Vertex Pharmaceuticals Incorporated
• 31.15. CRISPR Therapeutics AG

32. Global Recombinant DNA Technology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Recombinant DNA Technology Market

34. Recent Developments In The Recombinant DNA Technology Market

35. Recombinant DNA Technology Market High Potential Countries, Segments and Strategies

• 35.1 Recombinant DNA Technology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Recombinant DNA Technology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Recombinant DNA Technology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer